Loading...

MannKind Corporation

MNKDNASDAQ
Healthcare
Biotechnology
$3.56
$0.70(24.48%)
U.S. Market opens in 12h 33m

MannKind Corporation Fundamental Analysis

MannKind Corporation (MNKD) shows weak financial fundamentals with a PE ratio of 189.49, profit margin of 1.68%, and ROE of -11.21%. The company generates $0.4B in annual revenue with strong year-over-year growth of 22.23%.

Key Strengths

Cash Position15.70%
PEG Ratio-2.37
Current Ratio1.70

Areas of Concern

ROE-11.21%
We analyze MNKD's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 131.4/100 based on profitability, valuation, growth, and balance sheet metrics. The A grade reflects excellent fundamentals and strong overall stability.

Fundamental Health Score

A
131.4/100

We analyze MNKD's fundamental strength across five key dimensions:

Efficiency Score

Weak

MNKD struggles to generate sufficient returns from assets.

ROA > 10%
0.74%

Valuation Score

Moderate

MNKD shows balanced valuation metrics.

PE < 25
189.49
PEG Ratio < 2
-2.37

Growth Score

Moderate

MNKD shows steady but slowing expansion.

Revenue Growth > 5%
22.23%
EPS Growth > 10%
-80.00%

Financial Health Score

Excellent

MNKD maintains a strong and stable balance sheet.

Debt/Equity < 1
-9.28
Current Ratio > 1
1.70

Profitability Score

Weak

MNKD struggles to sustain strong margins.

ROE > 15%
-1120.85%
Net Margin ≥ 15%
1.68%
Positive Free Cash Flow
Yes

Key Financial Metrics

Is MNKD Expensive or Cheap?

P/E Ratio

MNKD trades at 189.49 times earnings. This suggests a premium valuation.

189.49

PEG Ratio

When adjusting for growth, MNKD's PEG of -2.37 indicates potential undervaluation.

-2.37

Price to Book

The market values MannKind Corporation at -21.77 times its book value. This may indicate undervaluation.

-21.77

EV/EBITDA

Enterprise value stands at 13.92 times EBITDA. This signals the market has high growth expectations.

13.92

How Well Does MNKD Make Money?

Net Profit Margin

For every $100 in sales, MannKind Corporation keeps $1.68 as profit after all expenses.

1.68%

Operating Margin

Core operations generate 11.08 in profit for every $100 in revenue, before interest and taxes.

11.08%

ROE

Management delivers $-11.21 in profit for every $100 of shareholder equity.

-11.21%

ROA

MannKind Corporation generates $0.74 in profit for every $100 in assets, demonstrating efficient asset deployment.

0.74%

Following the Money - Real Cash Generation

Operating Cash Flow

MannKind Corporation generates limited operating cash flow of $18.29M, signaling weaker underlying cash strength.

$18.29M

Free Cash Flow

MannKind Corporation produces free cash flow of $13.67M, offering steady but limited capital for shareholder returns and expansion.

$13.67M

FCF Per Share

Each share generates $0.04 in free cash annually.

$0.04

FCF Yield

MNKD converts 1.21% of its market value into free cash.

1.21%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

189.49

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

-2.37

vs 25 benchmark

P/B Ratio

Price to book value ratio

-21.77

vs 25 benchmark

P/S Ratio

Price to sales ratio

3.22

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

-9.28

vs 25 benchmark

Current Ratio

Current assets to current liabilities

1.70

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

-0.11

vs 25 benchmark

ROA

Return on assets percentage

0.007

vs 25 benchmark

ROCE

Return on capital employed

0.06

vs 25 benchmark

How MNKD Stacks Against Its Sector Peers

MetricMNKD ValueSector AveragePerformance
P/E Ratio189.4929.77 Worse (Expensive)
ROE-11.21%682.00% Weak
Net Margin1.68%-45016.00% (disorted) Weak
Debt/Equity-9.280.42 Strong (Low Leverage)
Current Ratio1.704.49 Neutral
ROA0.74%-16121.00% (disorted) Weak

MNKD outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews MannKind Corporation's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

290.12%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

107.46%

Industry Style: Defensive, Growth, Innovation

High Growth

FCF CAGR

147.26%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ